Literature DB >> 3490478

Cathepsin L inactivates alpha 1-proteinase inhibitor by cleavage in the reactive site region.

D A Johnson, A J Barrett, R W Mason.   

Abstract

The lysosomal cysteine proteinases cathepsin L and cathepsin B were examined for their effect on the neutrophil elastase inhibitory activity of human alpha 1-proteinase inhibitor (alpha 1PI). Human cathepsin L catalytically inactivated human alpha 1PI by cleavage of the bonds Glu354-Ala355 and Met358-Ser359 (the serine proteinase inhibitory site). Cathepsin B did not inactivate alpha 1PI, even when equimolar amounts of enzyme were employed. Cathepsin L is the first human proteinase shown to catalytically inactivate alpha 1PI. These findings, in conjunction with other reports, suggest that alpha 1PI contains a proteolytically sensitive region encompassing residues 350-358. Taken together with the discovery of the elastinolytic activity of cathepsin L (Mason, R. W., Johnson, D. A., Barrett, A. J., and Chapman, H. A. (1986) Biochem. J. 233, 925-927), the present findings emphasize the possible importance of cathepsin L in the pathological proteolysis of elastin and diminish the role that can be attributed to cathepsin B in such processes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490478

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  An approach to computer-aided inhibitor design: application to cathepsin L.

Authors:  S Sudarsanam; G D Virca; C J March; S Srinivasan
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Characterization and expression of AmphiCL encoding cathepsin l proteinase from amphioxus Branchiostoma belcheri tsingtauense.

Authors:  Yongjun Wang; Shicui Zhang; Zhenhui Liu; Hongyan Li; Lei Wang
Journal:  Mar Biotechnol (NY)       Date:  2005 Jul-Aug       Impact factor: 3.619

4.  Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts.

Authors:  L J Joseph; L C Chang; D Stamenkovich; V P Sukhatme
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 5.  Proteolytic networks in cancer.

Authors:  Steven D Mason; Johanna A Joyce
Journal:  Trends Cell Biol       Date:  2011-01-12       Impact factor: 20.808

6.  Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L.

Authors:  D Jean; J Hermann; F Rodrigues-Lima; M Barel; M Balbo; R Frade
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

7.  Elastinolytic activity of alveolar macrophages in smoking-associated pulmonary emphysema.

Authors:  T Muley; M Wiebel; V Schulz; W Ebert
Journal:  Clin Investig       Date:  1994-03

8.  Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.

Authors:  D H Perlmutter; J Travis; P I Punsal
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

9.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

Review 10.  Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.